Evidence map›Paper›PMID 39649930›Full record

ArticleAnnals of medicine and surgery (2012)2024

Comparison of predictors of survival among fulminant myocarditis patients undergoing veno-arterial extracorporeal membrane oxygenation in the adult and pediatric populations.

Yomna E Dean, Mohamed Doma, Ahson Afzal, Sameh Samir Elawady, Rafeek W Elmezayen, Bdoor Ahmed A Bamousa, Naila Iqbal, Muluken Zeleke Megiso, Sriharsha Kodurum, Adham Ramadan and 10 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of medicine and surgery (2012), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Yomna E DeanFaculty of Medicine, Alexandria University, Egypt.
Mohamed DomaFaculty of Medicine, Alexandria University, Egypt.
Ahson AfzalDow Medical College, Karachi, Pakistan.
Sameh Samir ElawadyDow Medical College, Karachi, Pakistan.
Rafeek W ElmezayenKafr El-sheikh University, Kafr El-sheikh, Egypt.
Bdoor Ahmed A BamousaAlfaisal University, Riyadh, Saudi Arabia.
Naila IqbalShadan Institute of Medical Sciences, Hyderabad, India.
Muluken Zeleke MegisoAddis Ababa University, Ethiopia.
Sriharsha KodurumJawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India.
Adham RamadanFaculty of Medicine, Alexandria University, Egypt.
Mahmoud El BahaieAl-Azhar University, Cairo, Egypt.
Ahmed MagdiFaculty of Medicine, Alexandria University, Egypt.
Fatima AfzalNeuro-Endovascular Surgery, Medical University of South Carolina (MUSC), SC, USA.
Helmy BadrTanta University, Tanta, Egypt.
Basant KatameshTanta University, Tanta, Egypt.
Dina IsmailJacobi Medical Centre, Albert Einstein College of Medicine, New York, USA.
Yasser EtmanDirector of Intensive Care Unit, Texas Health Rockwall Hospital, TX USA.
Yusef HazimehLebanese University, Beirut, Lebanon.ORCID https://orcid.org/0000-0002-5090-5997
Edward DarlingSUNY Upstate Medical University, NY, USA.
Hani AiashSUNY Upstate Medical University, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Fulminant myocarditis (FM) is a potentially life-threatening disease that requires emergency care. The authors' study aims to explore clinical outcomes and predictors of survival when using veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support for the treatment of FM in adult and pediatric patients to analyze differences between both populations. Methods: PubMed, Scopus, Web of Science, and Cochrane databases were searched for studies reporting the effect of VA-ECMO on patients diagnosed with fulminant myocarditis. Statistical analysis was performed using R version 4.2.2. Results: Forty-three studies were included in our analysis with a total of 1268 patients. Survival rates were 65% and 71% among adult and pediatric patients, respectively. Patients who didn't suffer from cardiac arrest prior to VA-ECMO had better chances of survival in both populations; adults (OR 0.44; Conclusion: Using VA-ECMO in patients with fulminant myocarditis can significantly improve survival outcomes, with improved prognosis observed with younger age among adults and absence of prior history of cardiac arrest in both groups.

Indexed as

extracorporeal membrane oxygenationmyocarditis

Identifiers

PMID39649930
PMCPMC11623825

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.